Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov;3(6):e219026.
doi: 10.1148/rycan.2021219026.

Radioligand Therapy for Metastatic Prostate Cancer

Brian J Burkett
Comment

Radioligand Therapy for Metastatic Prostate Cancer

Brian J Burkett. Radiol Imaging Cancer. 2021 Nov.
No abstract available

PubMed Disclaimer

Comment on

  • Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
    Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, Tagawa ST, Nordquist LT, Vaishampayan N, El-Haddad G, Park CH, Beer TM, Armour A, Pérez-Contreras WJ, DeSilvio M, Kpamegan E, Gericke G, Messmann RA, Morris MJ, Krause BJ; VISION Investigators. Sartor O, et al. N Engl J Med. 2021 Sep 16;385(12):1091-1103. doi: 10.1056/NEJMoa2107322. Epub 2021 Jun 23. N Engl J Med. 2021. PMID: 34161051 Free PMC article. Clinical Trial.

References

    1. Sartor O , de Bono J , Chi KN , et al. . Lutetium-177EN_DASHPSMA-617 for metastatic castration-resistant prostate cancer . N Engl J Med 2021. ; 385 ( 12 ): 1091 – 1103 . doi: 10.1056/nejmoa2107322 - DOI - PMC - PubMed